Kuang-Yao Yang
Overview
Explore the profile of Kuang-Yao Yang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
99
Citations
1107
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chang K, Leu S, Hu H, Chan M, Liang S, Yang K, et al.
Diagnostics (Basel)
. 2025 Jan;
15(2.
PMID: 39857042
Mechanical power (MP) refers to ventilator-delivered energy to the lungs, which may induce lung injury. We examined the relationship between MP and mortality in patients with acute respiratory distress syndrome...
2.
Lee P, Huang Y, Liu C, Chen S, Hsueh P, Ku S, et al.
J Microbiol Immunol Infect
. 2025 Jan;
58(1):1-6.
PMID: 39794196
Respiratory syncytial virus (RSV) is the most common pathogen for young children hospitalized with bronchiolitis and pneumonia. Most infections occur below 1 year of age. RSV is also a significant...
3.
Wu L, Lin T, Lin T, Liou Y, Tsai C, Yang K, et al.
Ther Adv Respir Dis
. 2024 Nov;
18:17534666241292242.
PMID: 39491813
Background: The latest guidelines discourage the use of long-acting beta-agonists/inhaled corticosteroids (LABA/ICS) for chronic obstructive pulmonary disease (COPD). However, there is a lack of evidence regarding the optimal subsequent treatment...
4.
Chang C, Huang J, Shen H, Sun C, Liao Y, Ko H, et al.
J Formos Med Assoc
. 2024 Nov;
PMID: 39488498
Background: Comparing the outcomes of intensive care unit (ICU) admitted COVID-19 patients during the Alpha and Omicron-dominated periods. Methods: Patients with critical COVID-19 disease, requiring ICU admission from May to...
5.
Hsu S, Yang K, Huang H, Chuang C, Chang C, Pun C, et al.
Eur J Pharmacol
. 2024 Aug;
980:176817.
PMID: 39089462
Infection-related lipopolysaccharide (LPS) release causes cytokine storm and acute lung injury. Emerging data show that the interleukin 6 (IL-6) inhibitor tocilizumab can improve lung damage in patients with sepsis. This...
6.
Lin Y, Yang K, Peng C, Chan M, Sheu C, Feng J, et al.
Infection
. 2024 Jul;
53(1):197-207.
PMID: 38995550
Background: Carbapenem-resistant gram-negative bacteria (CRGNB) present a considerable global threat due to their challenging treatment and increased mortality rates, with bloodstream infection (BSI) having the highest mortality rate. Patients with...
7.
Sun C, Lee W, Shen H, Yu W, Chen W, Chen H, et al.
Arch Gerontol Geriatr
. 2024 Jul;
126:105539.
PMID: 38954987
Introduction: This study endeavors to decipher the association between Activin A and PRISm, thereby addressing the potential of Activin A as a serum biomarker for early detection and long-term clinical...
8.
Shen H, Lee W, Sun C, Yu W, Chen W, Hsiao F, et al.
J Nutr Health Aging
. 2024 Jun;
28(8):100285.
PMID: 38861881
Objectives: The link between aging and pulmonary function decline is well-established, but the underlying mechanisms have yet to be fully revealed. Serum follistatin, a myokine implicated in muscle degeneration, may...
9.
Wang S, Teng C, Chan M, Yang K, Sheu C, Liang S, et al.
Int J Infect Dis
. 2024 Jun;
146:107128.
PMID: 38852767
Objectives: This study analyzed the risk and impact of developing pneumogenic bacteremia in patients with CRAB nosocomial pneumonia in ICU. Methods: This is multicenter retrospective study. Clinical outcomes were compared...
10.
Shen H, Huang J, Sun C, Liao Y, Ko H, Chang C, et al.
Eur J Med Res
. 2024 Apr;
29(1):243.
PMID: 38643153
Background: Despite vaccines' effectiveness in reducing COVID-19 infection rates and disease severity, their impact on critical patients presenting with acute respiratory failure is elusive. The aim of this study was...